Compare with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES TTK HEALTHCARE ALKEM LABORATORIES/
TTK HEALTHCARE
 
P/E (TTM) x 21.9 12.0 183.0% View Chart
P/BV x 5.3 1.7 303.9% View Chart
Dividend Yield % 0.9 0.9 103.3%  

Financials

 ALKEM LABORATORIES   TTK HEALTHCARE
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
TTK HEALTHCARE
Mar-19
ALKEM LABORATORIES/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs2,7201,215 223.9%   
Low Rs1,660610 272.1%   
Sales per share (Unadj.) Rs697.9444.4 157.0%  
Earnings per share (Unadj.) Rs96.117.2 557.3%  
Cash flow per share (Unadj.) Rs117.327.6 424.4%  
Dividends per share (Unadj.) Rs25.005.00 500.0%  
Dividend yield (eoy) %1.10.5 208.3%  
Book value per share (Unadj.) Rs515.2177.9 289.6%  
Shares outstanding (eoy) m119.5714.13 846.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.12.1 152.8%   
Avg P/E ratio x22.852.9 43.1%  
P/CF ratio (eoy) x18.733.0 56.6%  
Price / Book Value ratio x4.35.1 82.9%  
Dividend payout %26.029.0 89.7%   
Avg Mkt Cap Rs m261,87912,894 2,031.0%   
No. of employees `00014.32.3 619.9%   
Total wages/salary Rs m15,0551,307 1,151.9%   
Avg. sales/employee Rs Th5,822.62,715.7 214.4%   
Avg. wages/employee Rs Th1,050.5565.3 185.8%   
Avg. net profit/employee Rs Th802.0105.4 760.8%   
INCOME DATA
Net Sales Rs m83,4446,279 1,329.0%  
Other income Rs m1,04278 1,344.8%   
Total revenues Rs m84,4866,356 1,329.2%   
Gross profit Rs m14,734496 2,972.9%  
Depreciation Rs m2,528147 1,723.0%   
Interest Rs m65134 1,924.9%   
Profit before tax Rs m12,598393 3,208.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105149 742.0%   
Profit after tax Rs m11,493244 4,716.1%  
Gross profit margin %17.77.9 223.7%  
Effective tax rate %8.837.9 23.1%   
Net profit margin %13.83.9 354.9%  
BALANCE SHEET DATA
Current assets Rs m54,9602,717 2,022.7%   
Current liabilities Rs m32,4331,571 2,064.8%   
Net working cap to sales %27.018.3 147.9%  
Current ratio x1.71.7 98.0%  
Inventory Days Days8032 247.4%  
Debtors Days Days7247 154.7%  
Net fixed assets Rs m32,710991 3,300.7%   
Share capital Rs m239141 169.2%   
"Free" reserves Rs m61,3682,373 2,586.1%   
Net worth Rs m61,6072,514 2,450.3%   
Long term debt Rs m1,5923 46,835.3%   
Total assets Rs m99,4334,158 2,391.3%  
Interest coverage x20.412.6 161.4%   
Debt to equity ratio x00 1,911.4%  
Sales to assets ratio x0.81.5 55.6%   
Return on assets %12.26.7 183.0%  
Return on equity %18.79.7 192.5%  
Return on capital %21.016.9 123.8%  
Exports to sales %19.13.6 531.8%   
Imports to sales %3.00.5 603.6%   
Exports (fob) Rs m15,917225 7,068.0%   
Imports (cif) Rs m2,48331 8,022.3%   
Fx inflow Rs m16,061225 7,132.0%   
Fx outflow Rs m2,48371 3,491.6%   
Net fx Rs m13,578154 8,811.9%   
CASH FLOW
From Operations Rs m5,851173 3,380.0%  
From Investments Rs m-7,41497 -7,682.4%  
From Financial Activity Rs m792-307 -257.6%  
Net Cashflow Rs m-731-38 1,939.3%  

Share Holding

Indian Promoters % 66.9 65.4 102.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 3.7 894.6%  
FIIs % 0.0 5.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 25.8 -  
Shareholders   68,381 12,723 537.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA  PFIZER  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Nosedived 1,939 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended deep in the red.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Feb 26, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - AUROBINDO PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS